Eidos Therapeutics - 48 Year Dividend History | EIDX

Historical dividend payout and yield for Eidos Therapeutics (EIDX) since 1971. The current TTM dividend payout for Eidos Therapeutics (EIDX) as of May 23, 2019 is $0.00. The current dividend yield for Eidos Therapeutics as of May 23, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.012B $0.000B
Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. It discovers and develops novel oral therapy for the treatment of diseases caused by transthyretin amyloidosis. Eidos Therapeutics, Inc. is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $104.482B 11.81
Gilead Sciences (GILD) United States $84.781B 10.29
Bio-Techne Corp (TECH) United States $7.652B 52.21